Point72 Asset Management
KRRO icon

Point72 Asset Management’s Korro Bio KRRO Stock Holding History

Point72 Asset Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-531,969
Closed -$25.5M – 4042
2025
Q3 		$25.5M Sell
531,969
-8,105
-2% -$180K 0.04% 470
2025
Q2 		$6.75M Buy
540,074
+19,184
+4% +$276K 0.01% 873
2025
Q1 		$9.07M Buy
520,890
+26,893
+5% +$797K 0.02% 718
2024
Q4 		$18.8M Buy
493,997
+49,147
+11% +$2.53M 0.04% 475
2024
Q3 		$14.9M Sell
444,850
-11,235
-2% -$473K 0.04% 513
2024
Q2 		$15.4M Buy
456,085
+190,259
+72% +$10.5M 0.04% 467
2024
Q1 		$23.9M Hold
265,826
– – 0.06% 397
2023
Q4 		$12.7M Buy
+265,826
New +$8.76M 0.03% 608

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Point72 Asset Management's KRRO Position: Q4 2025 in Review

Point72 Asset Management sold out of Korro Bio (KRRO) in Q4 2025, closing a stake of 531,969 shares — an estimated $25.5M sold.

Point72 Asset Management first reported a position in KRRO in Q4 2023 and held it in 8 quarters. The position peaked at $25.5M in Q3 2025. 83 funds tracked by Wall St. Rank hold KRRO as of Q4 2025.

  • Point72 Asset Management reported no remaining Korro Bio position as of Q4 2025 after selling out during the quarter.
  • Point72 Asset Management sold 531,969 Korro Bio shares in Q4 2025, an estimated $25.5M.
  • Point72 Asset Management first reported a position in Korro Bio in Q4 2023 and held it in 8 quarters.
  • Point72 Asset Management's Korro Bio position peaked at $25.5M in Q3 2025.
  • 83 funds tracked by Wall St. Rank held Korro Bio as of Q4 2025.

Based on Point72 Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.